Advisory Services Network Has Increased Spectra Energy Partners LP (SEP) Stake; Baxter International (BAX) SI Decreased By 5.48%

March 24, 2018 - By Marguerite Chambers

Baxter International Inc (NYSE:BAX) had a decrease of 5.48% in short interest. BAX’s SI was 6.36 million shares in March as released by FINRA. Its down 5.48% from 6.73 million shares previously. With 3.20M avg volume, 2 days are for Baxter International Inc (NYSE:BAX)’s short sellers to cover BAX’s short positions. The SI to Baxter International Inc’s float is 1.25%. The stock decreased 1.92% or $1.26 during the last trading session, reaching $64.29. About 2.42M shares traded. Baxter International Inc. (NYSE:BAX) has risen 32.55% since March 24, 2017 and is uptrending. It has outperformed by 15.85% the S&P500.

Advisory Services Network Llc increased Spectra Energy Partners Lp (SEP) stake by 169.2% reported in 2017Q3 SEC filing. Advisory Services Network Llc acquired 6,895 shares as Spectra Energy Partners Lp (SEP)’s stock declined 4.02%. The Advisory Services Network Llc holds 10,970 shares with $487,000 value, up from 4,075 last quarter. Spectra Energy Partners Lp now has $15.88B valuation. The stock decreased 1.25% or $0.41 during the last trading session, reaching $32.33. About 961,922 shares traded or 46.93% up from the average. Spectra Energy Partners, LP (NYSE:SEP) has declined 3.32% since March 24, 2017 and is downtrending. It has underperformed by 20.02% the S&P500.

Baxter International Inc. provides a portfolio of renal and hospital products. The company has market cap of $34.73 billion. The firm operates through two divisions, Hospital Products and Renal. It has a 49.95 P/E ratio. The Hospital Products segment makes intravenous solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, parenteral nutrition therapies, infusion pumps, inhalation anesthetics, and biosurgery products.

Investors sentiment is 0.97 in 2017 Q3. Its the same as in 2017Q2. It is flat, as 38 investors sold Baxter International Inc. shares while 300 reduced holdings. only 76 funds opened positions while 253 raised stakes. 439.80 million shares or 0.96% less from 444.08 million shares in 2017Q2 were reported. Eaton Vance Mngmt, Massachusetts-based fund reported 323,377 shares. Bartlett & Lc has invested 1.5% in Baxter International Inc. (NYSE:BAX). Gamco Et Al holds 0.05% or 119,300 shares. Hm Payson And holds 0.14% of its portfolio in Baxter International Inc. (NYSE:BAX) for 52,058 shares. Ny State Common Retirement Fund stated it has 1.65M shares. Highvista Strategies accumulated 0.37% or 26,187 shares. Meiji Yasuda Life Insurance Communications owns 4,200 shares. Canal Insur Company accumulated 70,000 shares. 79,823 are held by Commonwealth Bancorp Of Aus. Fdx holds 0.06% or 34,997 shares. Autus Asset Limited Liability Corp accumulated 1.05% or 86,973 shares. State Of Wisconsin Inv Board invested in 428,390 shares. Peoples Financial has 14,200 shares for 0.51% of their portfolio. Wespac Ltd Liability Co holds 0.13% or 3,218 shares in its portfolio. San Francisco Sentry Investment Grp (Ca) accumulated 11,767 shares.

Since March 2, 2018, it had 0 buys, and 1 insider sale for $329,590 activity. $329,590 worth of Baxter International Inc. (NYSE:BAX) shares were sold by Shapazian Carole J.

Among 20 analysts covering Baxter International (NYSE:BAX), 12 have Buy rating, 0 Sell and 8 Hold. Therefore 60% are positive. Baxter International had 56 analyst reports since July 30, 2015 according to SRatingsIntel. On Wednesday, July 26 the stock rating was maintained by RBC Capital Markets with “Hold”. UBS initiated Baxter International Inc. (NYSE:BAX) on Tuesday, September 22 with “Neutral” rating. The rating was upgraded by Deutsche Bank on Tuesday, February 20 to “Buy”. The firm has “Buy” rating by BMO Capital Markets given on Tuesday, December 12. On Monday, November 13 the stock rating was maintained by BMO Capital Markets with “Buy”. Leerink Swann upgraded the shares of BAX in report on Tuesday, April 4 to “Outperform” rating. As per Monday, June 6, the company rating was reinitiated by JP Morgan. JP Morgan upgraded the shares of BAX in report on Tuesday, January 2 to “Overweight” rating. On Thursday, October 13 the stock rating was initiated by Wells Fargo with “Outperform”. The firm earned “Overweight” rating on Friday, June 30 by Cantor Fitzgerald.

Among 21 analysts covering Spectra Energy Partners LP (NYSE:SEP), 9 have Buy rating, 2 Sell and 10 Hold. Therefore 43% are positive. Spectra Energy Partners LP has $61 highest and $35 lowest target. $46.20’s average target is 42.90% above currents $32.33 stock price. Spectra Energy Partners LP had 57 analyst reports since July 23, 2015 according to SRatingsIntel. The firm earned “Overweight” rating on Friday, May 27 by JP Morgan. The rating was maintained by Jefferies with “Buy” on Thursday, September 7. The rating was maintained by RBC Capital Markets with “Buy” on Wednesday, December 13. The firm earned “Buy” rating on Monday, June 5 by RBC Capital Markets. Tudor Pickering upgraded Spectra Energy Partners, LP (NYSE:SEP) on Thursday, September 8 to “Buy” rating. As per Thursday, January 11, the company rating was downgraded by Wells Fargo. U.S. Capital Advisors downgraded the stock to “Overweight” rating in Thursday, January 4 report. On Friday, January 15 the stock rating was upgraded by Wells Fargo to “Outperform”. On Thursday, July 23 the stock rating was upgraded by Jefferies to “Buy”. Stifel Nicolaus maintained the shares of SEP in report on Monday, August 14 with “Buy” rating.

Advisory Services Network Llc decreased Lifepoint Health Inc (NASDAQ:LPNT) stake by 5,679 shares to 63 valued at $4,000 in 2017Q3. It also reduced Berkshire Hathaway Inc Del (BRKB) stake by 4,235 shares and now owns 22,106 shares. Rockwell Collins Inc (NYSE:COL) was reduced too.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: